|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Johns Hopkins University School of Medicine, Baltimore, MD.
Joel E. Gallant, MD, MPH, The Johns Hopkins University School of Medicine, 1830 E Monument St, 4th Floor, Baltimore, MD 21287-6220
Objective: To assess the long-term safety of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia (PCP).
Design: Analysis of data from a large prospective observational database.
Setting: HIV clinic at a large urban teaching hospital.
Patients: One hundred seventy-four patients who developed PCP after being enrolled in the database.
Results: Fifty-three patients (30%) received adjunctive corticosteroids and 121 (70%) did not. Survival did not differ between groups after adjusting for CD4 count (relative risk for adjunctive corticosteroids = 0.74, p = 0.13). There were no differences in the incidence of cytomegalovirus disease (adjunctive corticosteroids: 18.5 cases per 100 person-years vs no adjunctive corticosteroids: 15.7, p = 0.22), Mycobacterium avium complex (23.4 vs 27.0, p = 0.73), cryptococcal meningitis (1.8 vs 4.1, p = 0.58), toxoplasmosis (3.6 vs 11.0, p = 0.28), Kaposi's sarcoma (1.8 vs 2.2, p = 0.92), herpes simplex (27.1 vs 42.7, p = 0.66), herpes zoster (3.8 vs 6.9, p = 0.71), oropharyngeal candidiasis (18.9 vs 10.9, p = 0.09), or non-Hodgkin's lymphoma (3.5 vs 4.2, p = 0.92). Esophageal candidiasis was more common among adjunctive corticosteroid recipients (45.1 vs 26.6, p = 0.01). Results were similar for time to development of opportunistic conditions.
Conclusions: Adjunctive corticosteroids do not increase mortality or the risk of most common HIV-associated complications.
Key Words: acquired immunodeficiency syndrome glucocorticoids HIV infection Pneumocystis carinii pneumonia
Submitted on January 12, 1998
Accepted on April 30, 1998
This article has been cited by other articles:
![]() |
G. Bollee, C. Sarfati, G. Thiery, A. Bergeron, S. de Miranda, J. Menotti, N. de Castro, A. Tazi, B. Schlemmer, and E. Azoulay Clinical Picture of Pneumocystis jiroveci Pneumonia in Cancer Patients Chest, October 1, 2007; 132(4): 1305 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alves, J.M. Nicolas, J.M. Miro, A. Torres, C. Agusti, J. Gonzalez, A. Rano, N. Benito, A. Moreno, F. Garcia, et al. Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients Eur. Respir. J., January 1, 2001; 17(1): 87 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. JANTZ and S. A. SAHN Corticosteroids in Acute Respiratory Failure Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1079 - 1100. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |